{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:25Z","timestamp":1792796185172,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001036","name":"Australian Rotary Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"MS Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019999","name":"Trish Multiple Sclerosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jneuroim.2024.578347","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T17:01:52Z","timestamp":1713718912000},"page":"578347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis"],"prefix":"10.1016","volume":"390","author":[{"given":"Vivien","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele D.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578347_bb0005","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ana.22136","article-title":"Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis","volume":"68","author":"Balashov","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0030","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archneur.64.10.nct70002","article-title":"Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1\/2 trial","volume":"64","author":"Bar-Or","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype\u2013positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864403","article-title":"Nanoparticles for inducing antigen-specific T cell tolerance in autoimmune diseases","volume":"13","author":"Benne","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83\u201399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005853","article-title":"Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status","volume":"12","author":"Binder","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0060","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200190","article-title":"HLA-DRB1*15:01 and the MERTK gene interact to selectively influence the profile of MERTK-expressing monocytes in both health and MS","volume":"11","author":"Binder","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2249.2000.01334.x","article-title":"Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions","volume":"122","author":"Boven","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0075","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/dmcn.14233","article-title":"Body mass index trajectories in pediatric multiple sclerosis","volume":"61","author":"Brenton","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0080","doi-asserted-by":"crossref","first-page":"eabn1823","DOI":"10.1126\/sciadv.abn1823","article-title":"Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis","volume":"8","author":"Bronge","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0085","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1189\/jlb.3A0714-334R","article-title":"MERTK as negative regulator of human T cell activation","volume":"97","author":"Cabezo\u2019n","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa8038","article-title":"Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis","volume":"7","author":"Cao","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/ijms20010204","article-title":"Exploiting PLGA-based biocompatible nanoparticles for next-generation tolerogenic vaccines against autoimmune disease","volume":"20","author":"Cappellano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00674","article-title":"Tolerizing strategies for the treatment of autoimmune diseases: from ex vivo to in vivo strategies","volume":"11","author":"Cauwels","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni1551","article-title":"Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system","volume":"9","author":"Cayrol","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0110","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/embj.201488027","article-title":"Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming","volume":"33","author":"Dalod","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnen\/64.5.371","article-title":"Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis","volume":"64","author":"Davies","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034103","article-title":"Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis","volume":"7","author":"de Andr\u00e9s","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnen\/nlx114","article-title":"To the brain and back: migratory paths of dendritic cells in multiple sclerosis","volume":"77","author":"De Laere","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01964","article-title":"Shuttling tolerogenic dendritic cells across the blood\u2013brain barrier in vitro via the introduction of de novo C\u2013C chemokine receptor 5 expression using messenger RNA electroporation","volume":"8","author":"De Laere","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0145","year":"2013"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0020","series-title":"A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study of the Safety and Efficacy of Autologous Immunoregulatory Dendritic Cells in Patients With Type 1 Diabetes (Clinical trial registration No. NCT02354911)","year":"2024"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0155","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: how tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clim.2012.05.009","article-title":"Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients","volume":"144","author":"Elong Ngono","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ni.1704","article-title":"The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding","volume":"10","author":"Fazilleau","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0175","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1074\/mcp.M900001-MCP200","article-title":"Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients","volume":"8","author":"Fissolo","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0180","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2567.2008.02881.x","article-title":"The T-cell pool is anergized in patients with multiple sclerosis in remission","volume":"126","author":"Fransson","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0190","series-title":"Autoimmunity Reviews, 9th International Congress on Autoimmunity in Nice","first-page":"1126","article-title":"Targets of the humoral autoimmune response in multiple sclerosis","volume":"13","author":"Fraussen","year":"2014"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02393","article-title":"Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications","volume":"10","author":"Fucikova","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0200","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0205","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0210","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/eji.201242402","article-title":"Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis","volume":"42","author":"Gross","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0215","article-title":"Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis","volume":"3","author":"Gross","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0225","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1136\/ard.2009.126383","article-title":"Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis","volume":"69","author":"Harry","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0230","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.410190610","article-title":"Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions","volume":"19","author":"Hauser","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101694","article-title":"Recent advances of nanotechnology application in autoimmune diseases \u2013 a bibliometric analysis","volume":"48","author":"He","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0240","first-page":"3375","article-title":"MerTK is a functional regulator of myelin phagocytosis by human myeloid cells","volume":"196","author":"Healy","year":"2016","journal-title":"J.I."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0245","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000402","article-title":"MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS","volume":"4","author":"Healy","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4","article-title":"T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls","volume":"63","author":"Hellings","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0255","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2012.01.009","article-title":"Decreased interferon-\u03b1 production in response to CpG DNA dysregulates cytokine responses in patients with multiple sclerosis","volume":"143","author":"Hirotani","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1750-3639.2004.tb00496.x","article-title":"Expression of major histocompatibility complex class l molecules on the different cell types in multiple sclerosis lesions","volume":"14","author":"H\u00f6ftberger","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0270","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41582-022-00700-2","article-title":"Pathogenic autoantibodies in multiple sclerosis \u2014 from a simple idea to a complex concept","volume":"18","author":"H\u00f6ftberger","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.680581","article-title":"The role of B cells in primary progressive multiple sclerosis","volume":"12","author":"Holloman","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0280","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.it.2019.08.003","article-title":"Rebalancing immune homeostasis to treat autoimmune diseases","volume":"40","author":"Horwitz","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0285","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(99)00106-X","article-title":"Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines","volume":"99","author":"Huang","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2249.2000.01398.x","article-title":"Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats","volume":"122","author":"Huang","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2249.2001.01504.x","article-title":"Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-\u03b2 and IL-10","volume":"124","author":"Huang","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(01)00432-5","article-title":"Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis","volume":"121","author":"Hussien","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0310","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.4049\/jimmunol.164.7.3596","article-title":"Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation","volume":"164","author":"Hwu","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0315","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458520925369","article-title":"Aggressive multiple sclerosis (1): towards a definition of the phenotype","volume":"26","author":"Iacobaeus","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0320","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic cells as inducers of peripheral tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bib826","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0325","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.106.103259","article-title":"Inhibition of nuclear factor-\u03baB enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis","volume":"318","author":"Iruretagoyena","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0330","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa119","article-title":"Summary-data-based Mendelian randomisation prioritises potential druggable targets for multiple sclerosis","author":"Jacobs","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0335","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory Crohn\u2019s disease: a phase I study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"ECCOJC"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0345","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10\u2013producing, nonproliferating Cd4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0350","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(18)30069-3","article-title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","volume":"17","author":"Kapoor","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0355","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.177.6.4196","article-title":"Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response","volume":"177","author":"Karni","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/awy296","article-title":"Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions","volume":"142","author":"Kaunzner","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0365","doi-asserted-by":"crossref","DOI":"10.1177\/11795735211037785","article-title":"Breast carcinoma after Ocrelizumab therapy in multiple sclerosis patients: a case series and literature review","volume":"13","author":"Kelsey","year":"2021","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0370","first-page":"560","article-title":"Infectious tolerance: therapeutic potential","volume":"22","author":"Kendal","year":"2010","journal-title":"Curr. Opini. Immunol. Spec. Sect. Immune Tolerance \u25cf Immunogenet. Transplant."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0375","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-017-02406-2","article-title":"Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis","volume":"9","author":"Kimura","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0380","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/path.1434","article-title":"Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood\u2013brain barrier leakage and active demyelination","volume":"201","author":"Kirk","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00230","article-title":"Nanoparticles for the induction of antigen-specific immunological tolerance","volume":"9","author":"Kishimoto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0390","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis Optica Spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0395","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0400","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CDLI.6.1.14-19.1999","article-title":"Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study","volume":"6","author":"Kleeberger","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0405","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.1101638","article-title":"Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory T cells","volume":"187","author":"Kleijwegt","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0410","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3174\/ajnr.A1434","article-title":"First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T","volume":"30","author":"Kollia","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0415","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaut.2009.10.006","article-title":"T lymphocytes impair P-glycoprotein function during neuroinflammation","volume":"34","author":"Kooij","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0420","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0430","doi-asserted-by":"crossref","first-page":"21512","DOI":"10.1073\/pnas.2011249117","article-title":"Autoantibodies against central nervous system antigens in a subset of B cell\u2013dominant multiple sclerosis patients","volume":"117","author":"Kuerten","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0435","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/NEN.0b013e31816fc975","article-title":"Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta","volume":"67","author":"Lande","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0440","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200164","article-title":"Multiple sclerosis, disease-modifying therapies, and infections","volume":"10","author":"Langer-Gould","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0450","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0455","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0460","doi-asserted-by":"crossref","first-page":"15903","DOI":"10.3390\/ijms242115903","article-title":"The Tolerogenic influence of dexamethasone on dendritic cells is accompanied by the induction of Efferocytosis, promoted by MERTK","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0465","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","article-title":"Regulatory T cells inhibit dendritic cells by lymphocyte activation Gene-3 engagement of MHC class II1","volume":"180","author":"Liang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101730","article-title":"Using mass spectrometry to identify neoantigens in autoimmune diseases: the type 1 diabetes example","volume":"66","author":"Lichti","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0475","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000450854","article-title":"Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a Meta-analysis","volume":"47","author":"Liu","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0480","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5463879","article-title":"Immature dendritic cell therapy confers durable immune modulation in an antigen-dependent and antigen-independent manner in nonobese diabetic mice","volume":"2018","author":"Lo","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0485","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-0964-2","article-title":"\u03b2-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration","volume":"566","author":"Lodygin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0490","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-8-2","article-title":"Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse","volume":"8","author":"Longhini","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0495","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2300","article-title":"Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies","volume":"4","author":"Lord","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0500","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatics","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0505","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0510","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","article-title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0515","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640935","article-title":"Antigen-specific immune tolerance in multiple sclerosis\u2014promising approaches and how to bring them to patients","volume":"12","author":"Lutterotti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0525","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.173.7.4331","article-title":"Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic Cells1","volume":"173","author":"Machen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0530","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0535","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0540","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","article-title":"Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS","volume":"61","author":"Malmestr\u00f6m","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0545","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cns.12342","article-title":"Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis","volume":"21","author":"Mansilla","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0550","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12974-016-0584-9","article-title":"Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients","volume":"13","author":"Mansilla","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0555","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0560","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41582-019-0240-y","article-title":"Chronic inflammation in multiple sclerosis \u2014 seeing what was always there","volume":"15","author":"Matthews","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0565","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-5728(98)00002-2","article-title":"MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study","volume":"86","author":"McManus","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0570","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.182.1.75","article-title":"Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis","volume":"182","author":"McRae","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0575","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/awz017","article-title":"Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis","volume":"142","author":"Mexhitaj","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102450","article-title":"Autoantigenomics: holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases","volume":"19","author":"Moritz","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0585","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/eji.200425556","article-title":"The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells","volume":"35","author":"M\u00fcller","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0590","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","article-title":"Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis","volume":"24","author":"Murphy","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0595","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-immunol-032713-120204","article-title":"Transcriptional control of dendritic cell development","volume":"34","author":"Murphy","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0605","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0166-2236(02)02154-9","article-title":"Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases","volume":"25","author":"Neumann","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0610","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12974-023-02921-8","article-title":"Mertk-expressing microglia influence oligodendrogenesis and myelin modelling in the CNS","volume":"20","author":"Nguyen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0615","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1681\/ASN.2012070705","article-title":"The HLA-DRB1*15:01\u2013restricted Goodpasture\u2019s T cell epitope induces GN","volume":"24","author":"Ooi","year":"2013","journal-title":"JASN"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0620","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.3390\/ijms22168415","article-title":"Tolerogenic dendritic cell-based approaches in autoimmunity","volume":"22","author":"Passeri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103051","article-title":"Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases","volume":"138","author":"Passeri","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0630","series-title":"Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis (Clinical trial registration No. study\/NCT04530318)","author":"Pich","year":"2022"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0635","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-021-00738-5","article-title":"Induction of antigen-specific tolerance by nanobody\u2013antigen adducts that target class-II major histocompatibility complexes","author":"Pishesha","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0640","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry\u2013based identification of MHC-bound peptides for immunopeptidomics","volume":"14","author":"Purcell","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00569","article-title":"Tolerogenic dendritic cells for regulatory T cell induction in man","volume":"6","author":"Raker","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0650","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/eji.201141835","article-title":"Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients","volume":"42","author":"Ra\u03cach-Regu\u00e9","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0655","first-page":"eadd8693","article-title":"Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis. Science","volume":"9","author":"Rhodes","year":"2023","journal-title":"Advances"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0660","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-20-3760","article-title":"Opening of the blood\u2013brain barrier using low-intensity pulsed ultrasound enhances responses to immunotherapy in preclinical glioma models","volume":"27","author":"Sabbagh","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0665","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/acn3.199","article-title":"Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis","volume":"2","author":"Salou","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004970","article-title":"In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive Tregs involves IL-6\u2013mediated signaling","volume":"5","author":"Schneider","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0675","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.4049\/jimmunol.0903662","article-title":"An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis","volume":"184","author":"Schwab","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0685","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","article-title":"Human inflammatory dendritic cells induce Th17 cell differentiation","volume":"38","author":"Segura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0690","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41587-019-0015-4","article-title":"Antigen-specific therapeutic approaches for autoimmunity","volume":"37","author":"Serra","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0695","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archneurol.2011.2450","article-title":"Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study","volume":"69","author":"Sinnecker","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0700","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1110740","article-title":"Potassium channel KIR4.1 as an immune target in multiple sclerosis","volume":"367","author":"Srivastava","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0705","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm1715","article-title":"Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells","volume":"14","author":"Stromnes","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106275","article-title":"Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules","volume":"81","author":"\u0160vajger","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0715","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.26251","article-title":"COVID-19 vaccine response in people with multiple sclerosis","volume":"91","author":"Tallantyre","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0720","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0725","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00181","article-title":"Ways forward for tolerance-inducing cellular therapies- an AFACTT perspective","volume":"10","author":"ten Brinke","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0735","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0740","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/1352458513505352","article-title":"Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors","volume":"20","author":"Thewissen","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00945","article-title":"Nanoparticle platforms for antigen-specific immune tolerance","volume":"11","author":"Thorp","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0750","doi-asserted-by":"crossref","first-page":"e1191","DOI":"10.1212\/WNL.0000000000005257","article-title":"Sun exposure over the life course and associations with multiple sclerosis","volume":"90","author":"Tremlett","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0755","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","article-title":"Reversal of autoimmunity by boosting memory-like autoregulatory T cells","volume":"32","author":"Tsai","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0760","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrneurol.2017.171","article-title":"Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting","volume":"14","author":"Tur","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0765","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0770","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4049\/jimmunol.164.2.670","article-title":"Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis","volume":"164","author":"Vanderlugt","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0775","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.4049\/jimmunol.180.9.6411","article-title":"Natural naive CD4 + CD25 + CD127 low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression","volume":"180","author":"Venken","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0780","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.170.9.4483","article-title":"Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells","volume":"170","author":"Vieira","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0785","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0790","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030309","article-title":"Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration","volume":"9","author":"Willekens","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102873","article-title":"Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: a systematic review and meta-analysis of clinical trials","volume":"20","author":"Willekens","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0800","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1742-2094-11-57","article-title":"Comparison of microglia and infiltrating CD11c+ cells as antigen presenting cells for T cell proliferation and cytokine response","volume":"11","author":"Wlodarczyk","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2024.578347_bb0805","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.179.1.279","article-title":"Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones","volume":"179","author":"Wucherpfennig","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0810","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells","volume":"39","author":"Yin","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0815","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","article-title":"Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis","volume":"18","author":"Yong","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0820","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.4049\/jimmunol.168.10.5117","article-title":"B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent Fashion1","volume":"168","author":"Yu","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578347_bb0825","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T07:23:35Z","timestamp":1715325815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":165,"alternative-id":["S0165572824000651"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578347","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578347"}}